South Dakota IVC Filter Lawsuit Plaintiff Alleges Device Will Remain Lodged In Internal Organ

April 04, 2016 – – TheProductLawyers.com discusses potential IVC filter failures among patients, some of which have reportedly caused catastrophic damage, leaving those suffering from these occurrences with pain and suffering as well as emotional stress. Some patients may be left wondering when pieces of the vena cava filter which could not be retrieved but were supposed to be removed might surface and cause health problems.

These IVC filters, though originally intended to be used for a short period of time before being removed, reportedly end up remaining in patients permanently, and causing these patients long-term complications.

In the case of one South Dakota plaintiff, an Eclipse IVC filter was implanted to lower the risk of blood clots causing pulmonary embolism. The filter used was manufactured by C.R. Bard. These filters are placed into the patient via the inferior vena cava. The woman’s device was intended to be used temporarily and then retrieved after she was no longer at risk of developing pulmonary embolism.

The plaintiff reports, however, that the device was never able to be removed as intended. Instead, she alleges, it actually moved from its original location and traveled until it became stuck within her internal organs. She states that even surgery attempting to remove the device was not successful, and it remains in her internal organs to this day, putting her at risk for further complications; potentially even life-threatening ones. Each day, she indicates, she lives knowing that the potential for a sudden catastrophic medical emergency could occur at any point. For this reason, she decided to file suit against manufacturer C.R. Bard.

The U.S. Food and Drug Administration reported in 2010 that they had received 900 or more adverse event reports relating to inferior vena cava (IVC) migration, fracturing, embolization, and perforation. Just four years later, the agency followed up on these concerns by releasing a communication to physicians and the medical community, indicating that IVC filters should be removed from patients between 29 and 54 days after implantation.

In addition, a concerning study was published in the April 2013 issue of JAMA: Internal Medicine which highlighted that less than 10 percent of patients implanted with an IVC filter were able to later have the device successfully removed.

As lawsuits surrounding IVC devices continue to appear, the attorneys of Banville Law are working to assist others who may have suffered from medical complications after having an IVC filter implanted. Affected patients may be entitled to substantial compensation attained through legal action. Banville Law believes that all involved patients deserve the important opportunity to evaluate their legal rights in the matter, and are therefore currently offering free legal consultations for qualified individuals.

To request additional information concerning IVC filter lawsuits, or to ask questions, please contact the attorneys of Banville Law by calling 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
877-671-6480
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009046